title: Crescentic transformation of membranous glomerulopathy: a reversible condition.
authors.forename: Andrew M
authors.initials: AM
authors.lastname: Hall
authors.forename: Emily M
authors.initials: EM
authors.lastname: Symington
authors.forename: Stephen A
authors.initials: SA
authors.lastname: Sampson
authors.forename: Jonathan T C
authors.initials: JT
authors.lastname: Kwan
mesh_terms: D000284:Administration, Oral; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D015433:Glomerulonephritis, Membranous / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D007668:Kidney / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D011239:Prednisolone / Q000008:administration & dosage; D051437:Renal Insufficiency / Q000188:drug therapy / Q000209:etiology*
chemical_list: D000893:Anti-Inflammatory Agents; D018906:Antineoplastic Agents, Alkylating; D003520:Cyclophosphamide; D011239:Prednisolone